Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC
Michael J. Grant, Roy S. Herbst, Sarah B. Goldberg
Topics & Concepts
MedicineRegimenImmunotherapyOncologyClinical trialInternal medicineLung cancerIntensive care medicineCancerCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsLung Cancer Research Studies